Turkey is emerging as a prominent destination for ovarian cancer treatment, with several top-tier hospitals accredited by the Joint Commission International. Leading facilities such as Anadolu Medical Center, Valued Med Hub Hospitals, and Memorial Şişli Hospital offer cutting-edge treatments, including minimally invasive surgery, HIPEC (Hyperthermic Intraperitoneal Chemotherapy), and targeted therapy. The ovarian cancer survival rate in Turkey reaches 75%, with early-stage treatment success exceeding 80% due to advanced diagnostics and personalized treatment plans.
Anadolu Medical Center, affiliated with Johns Hopkins Medicine, is renowned for its multidisciplinary approach and American treatment standards, ensuring high-quality care. Valued Med Hub Hospitals, with its International Health Tourism Authorization Certificate, provides exceptional services in oncology, attracting patients worldwide. Memorial Şişli Hospital, the first in Turkey to receive JCI accreditation, boasts a 90% success rate in organ transplants, reflecting its expertise in complex medical procedures.